DataMeds AI, Inc. Investing Cash Flow
DataMeds AI, Inc. (MEDS) reported Investing Cash Flow of -$447.23 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-17
- DataMeds AI, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$242.13K.
- DataMeds AI, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$205.10K.
- DataMeds AI, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$255.38K, a 131.82% decline year-over-year.
- DataMeds AI, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$221.09K.
- DataMeds AI, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$881.53K, a 287.93% decline from fiscal 2024.
- DataMeds AI, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $469.07K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$242.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$447.23K 10-Q · filed 2026-08-17 | -$702.61K derived: sum of 3 quarters · filed 2026-08-17 | -$923.70K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | -$205.10K 10-Q · filed 2026-05-19 | -$460.48K derived: sum of 2 quarters · filed 2026-05-19 | -$681.57K derived: sum of 3 quarters · filed 2026-05-19 | -$813.49K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$255.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$476.47K derived: sum of 2 quarters · filed 2026-03-20 | -$608.39K derived: sum of 3 quarters · filed 2026-08-17 | -$881.53K 10-K · filed 2026-03-20 |
| 2025-09-30 | -$221.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$353.01K derived: sum of 2 quarters · filed 2026-08-17 | -$626.14K 10-Q · filed 2025-11-19 | $176.41K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$131.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$405.06K 10-Q · filed 2026-08-17 | $397.50K derived: sum of 3 quarters · filed 2026-08-17 | $81.56K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$273.13K 10-Q · filed 2026-05-19 | $529.42K derived: sum of 2 quarters · filed 2026-05-19 | $213.48K derived: sum of 3 quarters · filed 2026-05-19 | |
| 2024-12-31 | $802.55K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $486.62K derived: sum of 2 quarters · filed 2026-03-20 | $469.07K 10-K · filed 2026-03-20 | |
| 2024-09-30 | -$315.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$333.48K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | -$17.55K 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |